相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Chunxiao Xu et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis B virus induced hepatocellular carcinoma
I. Chemin et al.
CANCER LETTERS (2009)
Benefits and Risks of Nucleoside Analog Therapy for Hepatitis B
Jules L. Dienstag
HEPATOLOGY (2009)
Benefits and Risks of Interferon Therapy for Hepatitis B
Robert Perrillo
HEPATOLOGY (2009)
Hepatitis B: The Virus and Disease
T. Jake Liang
HEPATOLOGY (2009)
Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells
O. Hantz et al.
JOURNAL OF GENERAL VIROLOGY (2009)
The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV
Philip Meuleman et al.
ANTIVIRAL RESEARCH (2008)
Rescue of Fertility in Homozygous Mice for the Urokinase Plasminogen Activator Transgene by the Transplantation of Mouse Hepatocytes
Nicolas M. Brezillon et al.
CELL TRANSPLANTATION (2008)
Hepatitis B: Reflections on the current approach to antiviral therapy
Fabien Zoulim et al.
JOURNAL OF HEPATOLOGY (2008)
Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease
Patrick Soussan et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
J. J. Feld et al.
ANTIVIRAL RESEARCH (2007)
NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats
Chang Shi et al.
TOXICOLOGY LETTERS (2007)
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stephen J. Stray et al.
JOURNAL OF MOLECULAR RECOGNITION (2006)
Liver-stage development of Plasmodium falciparum, in a humanized mouse model
S Morosan et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly
SJ Stray et al.
NATURE BIOTECHNOLOGY (2006)
Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus
P Meuleman et al.
JOURNAL OF VIROLOGY (2006)
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
SJ Stray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera
P Meuleman et al.
HEPATOLOGY (2005)
Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes
M Dandri et al.
JOURNAL OF HEPATOLOGY (2005)
Near completely humanized liver in mice shows human-type metabolic responses to drugs
C Tateno et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion
HJ Hacker et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
K Deres et al.
SCIENCE (2003)
The alkylated imino sugar, n-(n-nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture
XY Lu et al.
JOURNAL OF VIROLOGY (2003)
A small molecule inhibits and misdirects assembly of hepatitis B virus capsids
A Zlotnick et al.
JOURNAL OF VIROLOGY (2002)
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model
O Weber et al.
ANTIVIRAL RESEARCH (2002)
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus
M Dandri et al.
HEPATOLOGY (2001)
分享论文
